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Abstract
Rationale—Serotonin and especially serotonin 2A (5-HT2A) receptor signaling are important in
the etiology and treatment of schizophrenia and affective disorders. We previously reported a
novel 5-HT2A receptor effector, increased transglutaminase (TGase)-catalyzed transamidation, and
activation of the small G protein Rac1 in A1A1v cells, a rat embryonic cortical cell line.
Objectives—In this study, we explore the signaling pathway involved in 5-HT2A receptor-
mediated Rac1 transamidation.
Methods—A1A1v cells were pretreated with pharmacological inhibitors of phospholipase C
(PLC) or calmodulin (CaM), and then stimulated by the 5-HT2A receptor agonist, 2,5-
dimethoxy-4-iodoamphetamine (DOI). Intracellular Ca2+ concentration and TGase-modified Rac1
transamidation were monitored. The effect of manipulation of intracellular Ca2+ by a Ca2+
ionophore or a chelating agent on Rac1 transamidation was also evaluated.
Results—In cells pretreated with a PLC inhibitor U73122, DOI-stimulated increases in the
intracellular Ca2+ concentration and TGase-modified Rac1 were significantly attenuated as
compared to those pretreated with U73343, an inactive analog. The membrane-permeant Ca2+
chelator, BAPTA-AM strongly reduced TGase-catalyzed Rac1 transamidation upon DOI
stimulation. Conversely, the Ca2+ ionophore ionomycin, at a concentration that induced an
elevation of cytosolic Ca2+ to a level comparable to cells treated with DOI, produced an increase
in TGase-modified Rac1 without 5-HT2A receptor activation. Moreover, the CaM inhibitor W-7,
significantly decreased Rac1 transamidation in a dose-dependent manner in DOI-treated cells.
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Conclusions—These results indicate that 5-HT2A receptorcoupled PLC activation and
subsequent Ca2+ and CaM signaling are necessary for TGase-catalyzed Rac1 transamidation, and
an increase in intracellular Ca2+ is sufficient to induce Rac1 transamidation.
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Introduction
Serotonin receptor signaling, especially 5-HT2A receptor signaling, has been implicated in
schizophrenia and affective disorders including anxiety, depression, and posttraumatic stress
disorder (Roth 1994; Weisstaub et al. 2006). However, the nature of the mechanisms
underlying these disorders and their treatments has not been elucidated, hindering the
development of better treatment approaches. We previously reported a novel signaling
pathway for the 5-HT2A receptor system that has the potential to be involved in these
disorders. Stimulation of 5-HT2A receptors causes transamidation of Ras-related C3
botulinum toxin substrate 1 (Rac1) in A1A1v cells, a rat cortical cell line (Dai et al. 2008).
However, the underlying molecular mechanisms by which the 5-HT2A receptor signaling
regulates transglutaminase (TGase)-catalyzed transamidation and activation of Rac1 are still
unclear. TGases are a family of enzymes that catalyze the transamidation, esterification, and
deamidation of peptide-bound glutamine residues. The transamidation reaction can result in
the addition of a free low-molecular weight amine or the cross-linking of a protein-bound
glutamine to a protein-bound lysine residue within or between proteins.
5-HT2A receptor activation can increase inositol 1,4,5-trisphosphate (IP3) via Gq/11-
mediated activation of phospholipase C (PLC) (Conn and Sanders-Bush 1984). PLC plays
an important role in intracellular signal transduction by hydrolyzing phosphatidylinositol
4,5-bisphosphate (PIP2), a membrane phospholipid, and thereby generating 2 second
messengers: IP3 which diffuses through the cytosol and releases Ca2+ from intracellular
endoplasmic reticulum (ER) stores and diacylglycerol (DAG). It has been reported that
TGase activity can be significantly enhanced in response to increased intracellular Ca2+
through IP3 generation (Zhang et al. 1998). Moreover, serotonin-mediated activation of
small G protein Cdc42 was dependent on PLC signaling pathways (Udo et al. 2005).
Rac1, one of the most extensively characterized members in the Rho family of small G
proteins, was initially discovered as a substrate for ADP-ribosylation induced by the C3
component of botulinum toxin (Didsbury et al. 1989). Subsequently, Rac1 and its
downstream effectors were identified as key signaling molecules in various cell functions,
such as cytoskeleton reorganization, cell transformation, axonal guidance, and cell migration
(Etienne-Manneville and Hall 2002). Since Rac1 is also an essential mediator in many
pathological conditions such as Salmonella invasion, tumor cell migration, and retinal
degeneration (Bourguignon et al. 2000; Brown et al. 2007), it is important to define cellular
signaling pathways that lead to post-translational modifications and activation of Rac1.
Like all members of the Rho superfamily, Rac1 functions as a molecular switch, cycling
between an inactive GDPbound state and an active GTP-bound state. Rho small G proteins
can be activated by different signal transduction pathways initiated by extracellular factors
such as plateletderived growth factor, insulin, or epidermal growth factor (Bishop and Hall
2000). Serotonin has also been shown to induce activation via TGase-catalyzed
transamidation of small G proteins in neurons, platelets, aortic smooth muscle cells, and
pancreatic beta cells (Dai et al. 2008; Guilluy et al. 2007; Paulmann et al. 2009; Walther et
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al. 2003). TGase catalyzes the transamidation between protein-bound glutamines and
primary amines such as serotonin in a Ca2+-dependent manner (Folk and Chung 1985).
Calmodulin (CaM) has been shown to increase TGase enzymatic activity. In the presence of
CaM, a membraneassociated erythrocyte TGase is activated at physiological and lower than
physiological Ca2+ concentrations (Billett and Puszkin 1991). Moreover, in the presence of
Ca2+, CaM enhanced TGase activity threefold in human platelets and the chicken gizzard
(Puszkin and Raghuraman 1985). A CaM inhibitor prevented TGase-catalyzed cross-linking
of huntingtin in cells co-transfected with mutant huntingtin and TGase (Zainelli et al. 2004).
Taken together, we hypothesize that 5-HT2A receptor stimulated TGase-catalyzed Rac1
transamidation is dependent on PLC-mediated increases in intracellular Ca2+ and is
regulated by CaM. To test this hypothesis, we examined the effects of PLC inhibition, CaM
inhibition, and manipulation of intracellular Ca2+ by means of a Ca2+ ionophore or a
chelating agent on TGase-modified Rac1 in response to 5-HT2A receptor activation in
A1A1v cells. Knowing the molecular pathway involved in 5-HT2A receptor-mediated
activation of TGase and subsequently Rac1 including the involvement of PLC, Ca2+, and
CaM will allow for rationally choosing targets to selectively regulate activation of Rac1
independently of other second messengers activated by 5-HT2A receptors and probe the




A1A1v cells, a rat cortical cell line, were grown on 100-mm2 plates coated with poly-L-
ornithine (Sigma, St Louis, MO) and maintained in 5% CO2 at 33°C, in Dulbecco's modified
Eagle medium (DMEM; Fisher Scientific, Pittsburgh, PA) containing 10% fetal bovine
serum (FBS; Fisher Scientific, Pittsburgh, PA). Before each experiment, cells were
maintained in DMEM with 10% charcoal-treated FBS for 48 h. Charcoal treatment of FBS
reduces the concentration of serotonin in the media to approximately 3 nM (Unsworth and
Molinoff 1992). Cells from passages 8–15 were used for all experiments.
Chemicals
The following chemicals were used in this study: (–)-1-(2,5-dimethoxy-4-iodoamphetamine
HCl (DOI; Sigma, St Louis, MO), U73122 (Tocris Bioscience Ellisville, MO), U73343
(Sigma, St Louis, MO), BAPTA-AM (Invitrogen, Carlsbad, CA), ionomycin (Invitrogen,
Carlsbad, CA), and W-7 hydrochloride (Tocris Bioscience Ellisville, MO).
Measurement of intracellular Ca2+ concentration
Cells were grown to 90% confluence in black-sided 96-well plates (Fisher Scientific,
Pittsburgh, PA). Cells were washed twice with modified Kreb's medium (135 mM NaCl, 5.9
mM KCl, 1.5 mM CaCl2, 1.2 mM MgCl2, 11.5 mM D-glucose, 11.6 mM Hepes, pH 7.3)
and then incubated in the same medium with 5 µM Fura-2 AM (Molecular Probes, Carlsbad,
CA), 0.1% bovine serum albumin, and 0.02% Pluronic F127 detergent for 60 min at 33°C in
the dark. After loading, the cells were washed twice and incubated in the dark in modified
Kreb's medium or pretreated with drugs for 30 min. Following 1 min of equilibration, the
cells were stimulated with a single injection of DOI (resulting in a final concentration of 3
µM DOI), and the response was recorded for 3 min in 5-s intervals. Fura-2 fluorescence
using 340- and 380-nm excitation and 510-nm emission was measured with a BioTek
fluorescence plate reader. After background fluorescence was subtracted, the ratio of
fluorescence at 340-nm excitation to that at 380-nm excitation was calculated and used as an
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index of the intracellular Ca2+ concentration (the 340/380 nm fluorescence ratio is positively
correlated with the absolute values of intracellular Ca2+ concentration).
Immunoprecipitation of TGase-modified protein
A1A1v cells were harvested and lysed using lysis buffer A (25 mM Tris–HCl, pH 7.5, 250
mM NaCl, 5 mM EDTA, 1% Triton X-100, and 1:1,000 protease inhibitor cocktail (Sigma,
St Louis, MO) containing 104 µM AEBSF, 0.08 µM aprotinin, 2 µM leupeptin, 4 µM
bestatin, 1.5 µM pepstatin A and 1.4 µM E-64). Protein concentration was determined using
the BCA Protein Assay kit (Pierce, Rockford, IL). Immunopurification of proteins
containing TGase-catalyzed bonds was performed using 81D4 mAb (mouse IgM) prebound
to Sepharose beads (Covalab, Lyon, France) using a protocol developed by Covalab and as
described previously (Dai et al. 2008). Briefly 20 µl of sepharose-81D4 beads were washed
three times in TBS/0.1% Tween 20 with gentle shaking for 15 min, followed by adding cell
lysate containing 200 µg of protein (1 µg/µl) to the washed beads and incubating for 2 h at
37°C. After incubation, the pellets were washed four times in TBS/0.1% Tween 20 for 15
min. Then 20 µl of loading buffer (50 mM Tris–HCl, pH 6.8, 2% SDS, 0.1% bromophenol
blue, 10% glycerol, and 5% β-mercaptoethanol) was added to the washed pellets followed
by 5-min incubation at 90°C. The samples were then centrifuged at 9,000×g for 2 min and
the supernatant was transferred and stored at −80°C until immunoblot analysis. It was
previously reported that the 81D4 antibody is specific for the Nε-(γ-glutamyl) lysine
isopeptide, i.e., the transamidation of a peptide bound lysine residue to a peptide-bound
glutamate residue (el Alaoui et al. 1991). Several other substrates similar to the Nε-(γ-
glutamyl) lysine isopeptide were found not to cross-react with the 81D4 antibody, however
transamidation of a peptide bound lysine to a free low-molecular weight amine was not
examined (el Alaoui et al. 1991). Our previous data suggest that the antibody also
recognizes transamidation of a peptide bound lysine to serotonin (Dai et al. 2008).
Immunoblot
Immunoaffinity purified proteins and cell lysates were separated on 12% SDS-
polyacrylamide gels and then electrophoretically transferred to nitrocellulose membranes.
Membranes were then incubated in blocking buffer (5% non-fat dry milk, 0.1% Tween 20,
×1 TBS) for 1 h at room temperature. Membranes were incubated overnight at 4°C with
primary antibodies on a shaker. Primary antibodies (Upstate Biotechnology, NY: anti-Rac1,
mouse IgG, 1:700; anti-Na+/K+ ATPase, mouse IgG, 1: 10000; Millipore, Billerica, MA:
anti-serotonin transporter (SERT) antibodies, rabbit, 1:1,000; Abcam, Cambridge, MA: anti-
lactate dehydrogenase, goat antibody conjugated to HRP, 1:4,000) were diluted in antibody
buffer (1% non-fat dry milk, 0.1% Tween 20, 1× TBS). The next day, membranes were
washed with TBS/0.1% Tween 20 and then incubated with goat-antimouse or goat-anti-
rabbit secondary antibody conjugated to HRP (Jackson ImmunoResearch, West Grove, PA)
diluted in antibody buffer. Membranes were washed and signal was detected using enhanced
chemiluminescence Western blotting detection reagents (Amersham Biosciences,
Piscataway, NJ). Using Scion Image for Windows (Scion, Frederick, MD), immunoblots
were quantified by calculating the integrated optical density (IOD) of each protein band on
the film.
Statistical analyses
Data are presented as mean±the standard error of the mean (SEM) and analyzed by one- or
two-way ANOVA. Post hoc tests were conducted using Bonferroni's multiple comparison
tests. GraphPad Prism 5.0 (GraphPad Software Inc., San Diego, CA) was used for all
statistical analyses. A probability level of p<0.05 was considered to be statistically
significant for all statistical tests.
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We previously reported that 5-HT2A receptor stimulation induced TGase-catalyzed Rac1
transamidation and activation in A1A1v cells (Dai et al. 2008). To test the dependence of
Rac1 transamidation on PLC activation, cells were pretreated with 5 µM of the PLC
inhibitor, U73122, or an inactive analog, U73343, for 30 min prior to the stimulation of 5-
HT2A receptors by 3 µM DOI. U73122 inhibits both PLC-mediated hydrolysis of PIP2 to
IP3 and the coupling of G protein-PLC activation. Changes in intracellular Ca2+ were
monitored by the 340/380 nm fluorescence ratio of the Fura-2-loaded cells. DOI stimulation
induced a robust increase (by at least 200%) in the intracellular Ca2+ concentration within
cells pretreated with U73343, whereas PLC inhibition by U73122 reduced the intracellular
Ca2+ response to DOI (Fig. 1a). In parallel experiments, TGase-modified Rac1 was
evaluated by immunoprecipitation using the 81D4 antibody directed against the TGase-
catalyzed covalent bond and immunoblots. There were significant increases in TGase-
modified Rac1 within DOI-stimulated cells, but pretreatment with U73122 significantly
attenuated DOI-induced Rac1 modification by TGase (Fig. 1b, c). These results suggest a
specific role of PLC upstream of Rac1 transamidation in A1A1v cells. Two-way ANOVA
indicates a significant main effect of DOI [F(1,8)=108.3; p<0.001] and U73122
[F(1,8)=29.99; p<0.001] on TGase-modified Rac1. There was also a significant interaction
between DOI and U73122 [F(1,8)=17.40; p<0.01]. The ubiquitously expressed Na+/K+
ATPase is a well established plasma membrane marker, and its function underlies essentially
all of mammalian cell physiology. To verify that the PLC inhibitor-mediated decrease in
Rac1-transamidation by TGase was not due to U73122-induced cellular toxicity, cell lysates
from the same experiment were examined on immunoblot with antibodies for Na+/
K+ATPase and lactate dehydrogenase. There are no significant differences in Na+/K+AT
Pase levels or lactate dehydrogenase among cells with different treatments (Fig. 1b). Similar
measurements were used in all of the following experiments.
Ca2+ chelation
In order to determine if TGase-modified Rac1 specifically depends on an increase in
intracellular Ca2+ upon 5-HT2A receptor activation, A1A1v cells were pretreated with
increasing concentrations of the membrane-permeant Ca2+ chelator, BAPTA-AM (0, 5, 10,
20 µM) for 30 min, then the cells were challenged by DOI. Dose-dependent reductions in
the DOI-mediated Ca2+ response were observed by measuring Fura-2 fluorescence (Fig. 2a).
Since 20 µM BAPTA caused the most significant inhibition in Ca2+ increases, it was used in
the parallel experiments to evaluate TGase-modified Rac1. DOI stimulation of cells without
BAPTA-pretreatment significantly increases the amount of TGase-modified Rac1 about
twofold compared with vehicle-stimulated cells, whereas pretreatment with BAPTA has a
notable inhibitory effect on DOI-induced Rac1 modification by TGase (Fig. 2b, c),
suggesting that an increase in intracellular Ca2+ is required for DOI-mediated Rac1
transamidation. Two-way ANOVA indicates a significant main effect of DOI [F(1,8)=37.09;
p<0.001] and BAPTA [F(1,8)=9.85; p<0.05] on TGase-modified Rac1. There was also a
significant interaction between DOI and BAPTA [F(1,8)=9.50; p<0.05].
Ca2+ ionophore
To determine if an increase in intracellular Ca2+ is sufficient to enhance Rac1 modification
by TGase, a Ca2+ ionophore, ionomycin was used to produce an elevation of cytosolic Ca2+
concentration without 5-HT2A receptor activation. Ionomycin is an effective and specific
Ca2+ carrier, so it has been used in studies of Ca2+ flux across plasma and ER membranes.
To determine the concentration of ionomycin that raises the levels of cytosolic Ca2+ to
levels comparable to 3 µM DOI (the concentration of DOI used to induce TGase-modified
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Rac1), serial dilutions of ionomycin (from 1,000 nM 12.5 nM) were tested for their ability to
induce increases in intracellular Ca2+. As shown in Fig. 3a, 25 nM ionomycin was able to
produce a comparable increase in cytosolic Ca2+ in comparison to 3 µM DOI, so this
concentration was used in the parallel experiments to measure the effects on TGase-
modified Rac1. After cells were treated with either 3 µM DOI or 25 nM ionomycin for 15
min, ionomycin mediated an increase in TGase-modified Rac1 to levels similar to those
induced by DOI. One-way ANOVA indicated there is no significant difference in TGase-
modified Rac1 between DOI- and ionomycin-treated cells. Taken together, these data
suggest an increase in intracellular Ca2+ via an ionophore can mimic 5-HT2A receptor-
induced cytosolic Ca2+ increases and is sufficient to induce TGase-catalyzed Rac1
transamidation.
CaM inhibition
TGase is not only a Ca2+-dependent enzyme, but its activity is also positively regulated by
CaM. Moreover, Ca2+ signaling in cells is mainly mediated by CaM, a potent Ca2+-binding
protein. The CaM inhibitor, W-7, binds with high affinity to CaM in the presence of Ca2+
and thereby inhibits the activation of CaM-dependent enzymes. To test whether CaM
modulates TGase-catalyzed transamidation of Rac1, cells were pre-incubated for 1 h with 0,
0.5, or 5 µM W-7 hydrochloride, and then stimulated with 3 µM DOI or vehicle for 15 min.
We found that in DOI-stimulated cells, the levels of TGase-modified Rac1 were
significantly higher than in vehicle-stimulated cells, whereas pretreatment with W-7
decreased DOI-stimulated Rac1 modification by TGase in a dose-dependent manner (Fig.
4). Two-way ANOVA indicates a significant main effect of DOI [F (1,12)=144.6; p<0.001]
and W-7 [F(2,12)=8.152; p<0.01] on TGase-modified Rac1. There was also a significant
interaction between DOI and W-7 [F(2,12)=5.01; p<0.05].
To test whether CaM modulates 5-HT2A receptor-mediated Ca2+ release, cells were pre-
incubated for 1.5 h with 0, 0.5, or 5 µMW-7 hydrochloride, and then stimulated with 3 µM
DOI or vehicle for 3 min. We found pretreatment with W-7, did not alter DOI-stimulated
Ca2+ release (Fig. 4a).
SERT expression in A1A1v cells
Western blots were prepared with the membrane fraction of rat dorsal raphe and frontal
cortex and whole cell lysates from A1A1v cells. A single major band is detected with an
antibody directed against the amino-terminus of SERT in A1A1v cells comparable to the
band in rat dorsal raphe and frontal cortex which are used as positive controls (Fig. 5a).
Discussion
Several lines of evidence indicate Gq/11-protein-coupled receptors, such as bradykinin or
endothelin-1 receptor, are able to stimulate the activation of Rac1 (Clerk et al. 2001; van
Leeuwen et al. 1999), but the mechanisms by which Rac1 becomes activated through these
receptors remains poorly characterized. Nevertheless, it is worth noting that the activation of
Rac1 is highly regulated by physiological stimuli, and aberrant activation occurs under many
pathological conditions such as Salmonella invasion, tumor cell migration, and retinal
degeneration (Bourguignon et al. 2000; Brown et al. 2007). Therefore, further studies that
delineate signaling pathways involved in Rac1 activation may uncover new potential
therapeutic targets for these diseases. We have previously demonstrated that the 5-HT2A
receptor, another Gq/11-protein-coupled receptor, is responsible for TGase-catalyzed
transamidation and activation of Rac1 in A1A1v cells based on the fact that selective 5-
HT2A/2C receptor agonist, but not 5-HT1A receptor agonist, induces transamidation of Rac1
by TGase. Moreover, expression of 5-HT2C receptors is not detectable in this cell line and a
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selective 5-HT2A receptor antagonist blocks Rac1 transamidation (Dai et al. 2008). In the
present study, we investigated the mechanisms involved in Rac1 transamidation in response
to 5-HT2A receptor stimulation. Our experimental results identified that PLC-mediated
increases in intracellular Ca2+ and subsequent CaM activation are required for 5-HT2A
receptor-mediated Rac1 transamidation. 5-HT2A receptor stimulation activates PLC which
catalyzes the hydrolysis of PIP2 into IP3. IP3 mobilizes Ca2+ from ER stores and thereby
increases the intracellular Ca2+ and leads to the activation of CaM. Our data suggest that
both Ca2+ and CaM activate TGase, which catalyzes transamidation of Rac1 to bioamines,
such as serotonin (Fig. 5).
Except for the 5-HT3 receptor, which is a ligand-gated ion channel, the other 5-HT receptors
belong to the G protein-coupled receptor (GPCR) superfamily. G proteins such as Gα12 and
Gα13, have been shown to transduce signals from GPCR to activate Rho small G proteins
(Suzuki et al. 2003). One of the guanine nucleotide exchange factors (GEFs) for Rho,
p115RhoGEF, has served as a direct link between Gα12/Gα13 and Rho (Kozasa et al. 1998).
However, the signaling pathways between 5-HT2A receptors and Rac1 transamidation and
activation are not well understood. 5-HT2A receptor is primarily coupled to Gq/11 and
activates various isoforms of PLC (Conn and Sanders-Bush 1984). It also induces the
activation of phospholipase A2 and the release of arachidonic acid (Felder et al. 1990).
Moveover, through interaction with ADP-ribosylation factor 1 via its C-terminal domain, 5-
HT2A receptor is able to signal through the phospholipase D pathway (Robertson et al.
2003). Our results suggest that 5-HT2A receptor activation triggers TGase-catalyzed Rac1
transamidation predominantly through a pathway involving PLC (Fig. 1).
Although it has been reported that PLC activates Rac1 in a manner dependent on Iba1, a
Ca2+-binding protein specifically expressed in macrophage/microglia (Kanazawa et al.
2002), Rac1 transamidation and activation in A1A1v cells, a neuronal cell line, could be
mediated by other signaling pathways. Cleavage of PIP2 by PLC yields two important
second messengers, IP3 and DAG, to initiate a variety of cellular functions. Since Ca2+
chelation reduces DOI-stimulated Rac1 transamidation to basal levels (Fig. 2), IP3-induced
Ca2+ release rather than DAG signaling plays a pivotal role in TGase-catalyzed Rac1
transamidation. These results are in agreement with an earlier study suggesting that in
thrombin- and collagen-stimulated human blood platelets, PLC activity and an increase in
intracellular Ca2+ concentration were required for Rac1 activation, whereas PKC inhibition
had no effect (Soulet et al. 2001). Increases in intracellular Ca2+ concentration upon 5-HT2A
receptor stimulation are achieved by releasing intracellular Ca2+ stores and/or by activating
Ca2+ channels, depending on the cell of interest. 5-HT2A receptor-induced contraction of rat
aorta may require the concerted action of voltage-gated Ca2+ channels and phosphoinositide
turnover (Nakaki et al. 1985). More interestingly, stimulation of 5-HT2A receptors on
astrocytes caused Ca2+ influx through voltage independent Ca2+ channels which were
dependent of the IP3 production and subsequent Ca2+ release from internal stores (Hagberg
et al. 1998). Therefore, both Ca2+ mobilization from internal stores and influx of
extracellular Ca2+ could contribute to the PLC/IP3-mediated intracellular Ca2+ increase in
A1A1v cells.
CaM and TGase are Ca2+-dependent proteins. CaM activation is coupled to intracellular
Ca2+ elevation and also correlates with the spatial pattern of increased Ca2+ (Hahn et al.
1992). Upon Ca2+ binding to the EF hand motifs of CaM, both N- and C-terminal domains
adopt an open confirmation, exposing hydrophobic surfaces, which then interact with a
variety of target proteins including TGase (Puszkin and Raghuraman 1985; Zainelli et al.
2004). TGases contain a cysteine in their active site that is unmasked only in the presence of
Ca2+ (Hand et al. 1993) and Ca2+ activation of TGase is further regulated by other signal
modulators such as GTP and CaM (Puszkin and Raghuraman 1985; Zainelli et al. 2004). In
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order for TGase to become receptive to the glutamine substrate, Ca2+ first must bind to
TGase, inducing its conformational change which permits the glutamine substrate binding to
the catalytic center (Folk 1983). A rise of Ca2+ concentration increases TGase activity in a
dose-dependent manner in vitro and in cells (Shin et al. 2004; Siefring et al. 1978).
Consistent with these results, the elevation of intracellular Ca2+ induced via a Ca2+
ionophore lead to increased TGase-catalyzed Rac1 transamidation (Fig. 3).
In addition to Ca2+, CaM also interacts with TGase and regulates its cross-linking activity.
CaM has been shown to coimmunoprecipitate with TGase2 in transfected cells (Zainelli et
al. 2004). CaM increased TGase activity in human erythrocyte (Billett and Puszkin 1991),
platelets, and chicken gizzard (Puszkin and Raghuraman 1985). Interestingly, exogenous
CaM with a binding site on the α-subunits of the hexadecameric phosphorylase kinase
molecule (αβγδ)4, stimulates TGase-catalyzed incorporation of putrescine into the β- and γ-
subunits, but inhibits incorporation of amines into the α-subunit (Nadeau and Carlson 1994).
Some of the CaM antagonists, such as dansylcadaverine, inhibit TGase (Lorand et al. 1979)
and its protein cross-linking ability. We have previously reported that a CaM antagonist or
inhibitory CaM fragments, attenuated TGase-modified mutant huntingtin in cell and animal
models of Huntington's disease (Dai et al. 2009; Dudek et al. 2009; Zainelli et al. 2004).
CaM antagonists and Ca2+ chelators also have been shown to depress the motile progression
of sperm cells possibly mediated by TGase-catalyzed cross-linking of the contractile
proteins (Cariello and Nelson 1985). Our present results revealed that the CaM inhibitor,
W-7, reduced TGase-modified-Rac1 in dose-dependent fashion (Fig. 4), indicating that
TGase-catalyzed Rac1 transamidation, at least in part, was positively regulated by CaM.
Moreover, in the presence of a 5-HT2a receptor agonist, CaM has been shown to interact
with 5-HT2a receptors at the sites that are important for G protein coupling, suggesting a
putative role for CaM in regulating 5-HT2a receptor function (Turner and Raymond 2005).
However, since the CaM inhibitor had no effect on DOI-stimulated calcium release, the
effect of CaM inhibition is not likely mediated by alterations in signaling at the 5-HT2A
receptor but by modulation of TGase activity.
The significance of TGase in Rac1 transamidation was confirmed by TGase siRNA and a
chemical inhibitor in our previous studies (Dai et al. 2008). In addition to small G proteins
such as Rac1, RhoA, Rab3a, and Rab27a (Dai et al. 2008; Paulmann et al. 2009; Walther et
al. 2003) that could undergo TGase-catalyzed transamidation to serotonin (serotonylation),
more recently, cytoskeletal proteins including actin, myosin heavy chain, and filamin A have
been identified as serotonylated proteins (Watts et al. 2009). However, serotonin may not be
the only amine that could be incorporated in these proteins. Neuronal differentiation of SH-
SY5Y cells induced by retinoic acid increases the expression/activation of TGases, resulting
in transamidation of putrescine to RhoA and activation of RhoA (Singh et al. 2003).
Moreover, spermidine and putrescine are suitable substrates for transglutaminase-catalyzed
transamidation of RhoA in vitro (Schmidt et al. 2001). In addition to amine incorporation,
another important TGase-catalyzed modification of small G proteins is deamidation of
glutamine residues. However, this reaction has only been demonstrated by bacterial toxins,
not in mammalian systems and transglutaminases. The site-specific deamidation of Gln53
and Gln61 of RhoA and Ras, respectively, by bacterial toxins with TGase activity inhibits
the GTPase activity and renders small G proteins constitutively active (Lorand and Graham
2003).
In conclusion, our study provides important new insights into the signaling mechanisms
underlying 5-HT2A receptor-induced Rac1 transamidation and activation by TGase in
A1A1v cells, and highlights the necessity of PLC-mediated Ca2+ mobilization and CaM in
TGase-catalyzed Rac1 transamidation. As an activating signal for both TGase and CaM, an
elevation of intracellular Ca2+ is sufficient to induce Rac1 transamidation. Accumulating
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evidence suggests that Rho and Rab family of small G proteins are subject to TGase-
mediated modification and activation. The essential role of Rac1 in neuronal development,
especially in the regulation of dendritic spines (Corbetta et al. 2009; Tsai et al. 2009), axon
formation and guidance (Ng et al. 2002), neurite outgrowth and differentiation (Li et al.
2002) is well characterized, and perturbations in Rac1 signaling have been associated with
cognitive disorders such as mental retardation (Govek et al. 2005). Given the importance of
Rac1 in various pathophysiological processes, the biological functions of Rac1 activation by
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Effect of PLC inhibition on DOI-induced Ca2+ signals and TGase-modified Rac1 in A1A1v
cells. a After pretreatment with 5 µM U73122 or U73343 (negative control) for 30 min, and
stimulation with either 3 µM DOI or vehicle (Ve) for 15 min, changes in the fluorescence
ratio (340/380 nm) were recorded from cells loaded with Fura-2. A representative example
from three independent experiments conducted in triplicate is shown. Arrows indicate the
time of drug application. b Upper, immunoprecipitation (IP) and immunoblot (IB) analyses
revealed that U73122 pretreatment inhibited the increase in TGase-modified Rac1 upon DOI
stimulation. Middle and lower, cells lysates from the same experiment were examined on IB
with Na+/K+ ATPase and lactate dehydrogenase (LDH) antibodies respectively, which
indicate that U73122 had no effect on cell viability. c Quantitation of effects of U73122 and
DOI on TGase-modified Rac1 in three separate experiments. Data shown were the mean
IOD±S.E. M., and they were normalized to U73343- and Ve- treated cells. Two-way
ANOVA followed by Bonferroni test: one asterisk and three asterisks indicated p<0.05 and
0.001 as compared to U73343- and Ve-treated cells, respectively; one number sign indicated
p<0.001 as compared to U73343- and DOI- treated cells
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Pre-incubation with a Ca2+ chelator attenuated the DOI-mediated elevation of cytosolic
Ca2+ and TGase-modified Rac1. a Dynamic changes in the fluorescence ratio (340/380 nm)
in Fura-2 loaded A1A1v cells. The Ca2+ response to exposure to 3 µM DOI was gradually
reduced with the increasing concentrations of BAPTA. A representative example of three
independent experiments conducted in triplicate is shown. b Upper, cells were pretreated
with 20 µM BAPTA or the vehicle for BAPTA (Ve1) for 30 mins, and then stimulated with
3 µM DOI or the vehicle for DOI (Ve2) for 15 mins. TGase-modified Rac1 was detected by
IP and IB analysis. BAPTA inhibited the increase in TGase-modified Rac1 in DOI-
stimulated cells. Middle and lower, cells lysates from the same experiment were examined
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on IB with Na+/K+ATPase and LDH antibodies respectively. There was no significant
difference among various treatments. c Quantitation of effects of BAPTA and DOI on
TGase-modified Rac1 in three separate experiments. Data shown were the mean IOD±S.E.
M., and they were normalized to Ve1- and Ve2- treated cells. Two-way ANOVA followed
by Bonferroni test: one asterisk indicated p<0.001 as compared to Ve1- and Ve2- treated
cells; one number sign and two number signs indicated p<0.05 and p<0.001 as compared to
Ve1- and DOI- treated cells, respectively
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The Ca2+ ionophore mimicked the DOI-induced increase in cytosolic Ca2+ and TGase-
catalyzed transamidation of Rac1. a Fura-2-loaded cells were stimulated with either 3 µM
DOI or different concentrations of ionomycin. The changes in the fluorescence ratio
(340/380 nm) were recorded. A representative example from three independent experiments
conducted in triplicate is shown. b Upper, cells were treated for 15 mins with 3 µM DOI, 25
nM ionomycin or vehicle (Ve). Ionomycin caused an increase in TGase-modified Rac1
comparable to that induced by DOI. Middle and lower, cell viability, as indicated by Na+/
K+ATPase and LDH levels was not significantly different among the various treatments. c
Quantitation of effects of ionomycin and DOI on TGase-modified Rac1 in three separate
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experiments. Data shown were the mean IOD±S.E.M., and were normalized to Ve-1-treated
cells. One-way ANOVA followed by Bonferroni test: one asterisk indicates p<0.01 as
compared to Ve-1-treated cells; one number sign indicates p<0.01 as compared DOI-treated
cells
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The CaM inhibitor W-7 caused a dose-dependent reduction in DOI-stimulated TGase-
modified Rac1. a Pretreatment with the CaM inhibitor W-7 had no effect on DOI-stimulated
Ca2+ release. Data shown from one representative experiment performed in triplicate and
repeated two additional times. b Cells were pretreated with increasing concentrations of W-7
for 1 h and then stimulated with either 3 µM DOI or vehicle (Ve). TGase-modified Rac1,
Na+/K+ATPase and LDH were measured by IP and/or IB. W-7 decreased the levels of
TGase-modified Rac1 upon DOI stimulation, but did not significantly affect Na+/K+ATPase
or LDH levels at the concentrations of W-7 applied. c Quantitation of effects of W-7 on
TGase-modified Rac1 in three separate experiments. Data shown were the mean IOD
Dai et al. Page 18













±S.E.M., and were normalized to Ve-stimulated cells without W-7 pretreatment. Two-way
ANOVA followed by Bonferroni test: one asterisk and three asterisks indicate p<0.05 and
p<0.001 as compared to Ve-stimulated cells without W-7 pretreatment, respectively; one
number sign and two number signs indicate p<0.01 and p<0.001 as compared to DOI-
stimulated cells without W-7 pretreatment, respectively
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a Western blot demonstrating the presence of SERT in A1A1v cells. A Western blot was
prepared with 2.5 µg of the membrane fraction of rat dorsal raphe (DR) and frontal cortex
(FC) and compared to 20 µg of lysate from A1A1v cells. b Schematic representation
showing 5-HT2A receptor signal-mediated transamidation of Rac1 by TGase. DOI stimulates
Gq/11 proteins-coupled 5-HT2A receptors, leading to the activation of PLC, which in turn
hydrolyses PIP2 into IP3. IP3 releases Ca2+ from ER and results in the activation of Ca2+-
dependent proteins, such as CaM and TGase. Positively regulated by both Ca2+ and CaM,
TGase catalyzes transamidation of Rac1 to bioamines, such as serotonin (Dai et al. 2008)
transported into the cytoplasm by SERT. Abbreviations: 5-HT2AR5-HT2A receptor; CaM,
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calmodulin; ER, endoplasmic reticulum; PLC, phospholipase C; PIP2, phophatidyl
inositol-1,4-bisphosphate; IP3, inositol-1,4,5-triphosphate; SERT, serotonin transporter;
TGase, transglutaminase; α, β, γ, G protein α,β,γ subunits
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